- Home
- FGBI vs PRQR Comparison
FGBI vs PRQR Comparison
Compare FGBI & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FGBI | PRQR |
|---|---|---|
| Founded | 1934 | 2012 |
| Country | United States | Netherlands |
| Employees | 346 | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.6M | 244.1M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | FGBI | PRQR |
|---|---|---|
| Price | $8.99 | $1.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.25 |
| AVG Volume (30 Days) | 67.5K | ★ 1.6M |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.44% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $567.70 | N/A |
| Revenue Next Year | N/A | $13.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.31 | $1.33 |
| 52 Week High | $11.02 | $3.10 |
Technical Indicators
Market Signals| Indicator | FGBI | PRQR |
|---|---|---|
| Relative Strength Index (RSI) | 41.54 | 50.08 |
| Support Level | $8.72 | $1.37 |
| Resistance Level | $9.94 | $1.76 |
| Average True Range (ATR) | 0.36 | 0.13 |
| MACD | -0.09 | -0.00 |
| Stochastic Oscillator | 26.14 | 43.30 |
Price Performance
Historical ComparisonAbout FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.